Background-Treatment of right ventricular outflow tract obstruction is possible with a bare metal stent (BMS), although this treatment causes pulmonary regurgitation. In this study, we assessed the acute physiological effects of BMS versus percutaneous pulmonary valve implantation (PPVI) using an x-ray/magnetic resonance hybrid laboratory. Methods and Results-Fourteen consecutive children (median age, 12.9 years) with significant right ventricular outflow tract obstruction underwent BMS followed by PPVI. Magnetic resonance imaging (ventricular volumes and function and great vessel blood flow) and hemodynamic assessment (invasive pressure measurements) were performed before BMS, after BMS, and after PPVI; all were performed under general anesthesia in an x-ray/magnetic resonance hybrid laboratory. BMS significantly reduced the ratio of right ventricular to systemic pressure (0.75Ϯ0.17% versus 0.41Ϯ0.14%; PϽ0.001) with no further change after PPVI (0.42Ϯ0.11; Pϭ1.0). However, BMS resulted in free pulmonary regurgitation (21.3Ϯ10.7% versus 41.4Ϯ7.5%; PϽ0.001), which was nearly abolished after PPVI (3.6Ϯ5.6%; PϽ0.001). Effective right ventricular stroke volume (right ventricular stroke volume minus pulmonary regurgitant volume) after BMS remained unchanged (33.8Ϯ7.3 versus 32.6Ϯ8.7 mL/m 2 ; Pϭ1.0) but was significantly increased after revalvulation with PPVI (41.0Ϯ8.0 mL/m 2 ; Pϭ0.004). These improvements after PPVI were accompanied by a significant heart rate reduction (75.5Ϯ17.7 bpm after BMS versus 69.0Ϯ16.9 bpm after PPVI; Pϭ0.006) at maintained cardiac output (2.5Ϯ0.5 versus 2.4Ϯ0.5 versus 2.7Ϯ0.5 mL · min Ϫ1 · m Ϫ2 ; Pϭ0.14). 
S urgical repair of complex congenital heart disease often involves placement of a right ventricle (RV) to pulmonary artery (PA) conduit. Although surgical conduit placement can be performed with very low mortality, the lifespan of conduits is limited, reported to be Ͻ10 years. [1] [2] [3] [4] Conduit degeneration leads to obstruction with or without pulmonary regurgitation. Thus, the majority of patients with conduits from the RV to PA undergo multiple operations during their lifetime.
Clinical Perspective on p 3001
Bare metal stenting (BMS) has been proposed as a treatment option to prolong the lifespan of conduits. [5] [6] [7] [8] [9] [10] This treatment leads to the successful relief of obstruction but replaces a hemodynamically significant stenotic lesion with free pulmonary regurgitation. Although many studies have shown that BMS results in a significant reduction in the gradient across the conduit, in RV pressures, and in the ratio of RV to systemic pressure, [5] [6] [7] [8] [9] [10] the acute consequences of pulmonary regurgitation after BMS are not well described and cannot be fully assessed by catheter data alone.
Over the last few years, percutaneous pulmonary valve implantation (PPVI) has become a reality. With this technique, a competent valve can be implanted safely and effectively to relieve conduit obstruction without causing free pulmonary incompetence. [11] [12] [13] [14] [15] In our institution, we are increasingly performing BMS before PPVI to provide a more suitable anchoring environment for PPVI and potentially to reduce the risk for stent fracture of the valved stent. 16 More recently, combined catheterization/magnetic resonance (MR) technology has become available. [17] [18] [19] [20] Such catheterization/MR hybrid laboratories (x-ray/MR hybrid laboratories) have the potential to accurately assess changes in acute physiology not only with regard to pressure measurements but also by measuring ventricular dimensions/function and great vessel blood flow. In this study, we assess children undergoing sequential BMS and PPVI in the setting of an x-ray/MR hybrid laboratory to describe the acute physiological consequences of the 2 procedures.
Methods

Patients
In this prospective study, 14 consecutive children were studied between September 2007 and June 2008. Children were included when they had a clinical indication for PPVI in the context of significant RV outflow tract (RVOT) obstruction. 11 In symptomatic patients, this was defined as a ratio of RV to systemic pressure of Ͼ0.66. In the absence of symptoms, this ratio had to be Ͼ0.75. In addition, patients had to fulfill morphological requirements for PPVI, as previously published. 11 Briefly, the dimensions of the RVOT had to range between 14 and 22 mm as assessed by MR imaging within 1 month of the procedure. Exclusion criteria were unfavorable morphology for PPVI, 11, 21 occluded central veins, active infection, and/or contraindications to MR imaging. All investigations and interventions were performed at the Great Ormond Street Hospital for Children (London, UK). The study was approved by the institution's ethics committee. Written consent was obtained from patients and parents/guardians as appropriate.
Patients were assigned to New York Heart Association functional classes 1 to 4. Transthoracic echocardiography was performed in all patients. The RVOT gradient was calculated from the velocity across the RVOT and RV systolic pressure estimated from the tricuspid regurgitant jet. 22 Systemic pressures were derived from noninvasive blood pressure measurements; the ratio of RV to systemic pressure was calculated.
Catheterization/MR Study Protocol
The impact of BMS and PPVI on biventricular physiology was assessed in a 2-staged sequential procedure, with patients serving as their own controls. All patients were mechanically ventilated via cuffed tracheal tubes. Anesthesia was induced by either intravenous propofol (10 of 14) or inhaled sevoflurane and maintained by either inhaled isoflurane (9 of 14) or sevoflurane (only 1 maintenance vapor was used in each patient). All patients were given a muscle relaxant to effect tracheal intubation and maintain immobility throughout the procedure. The concentration of anesthetic vapor was adjusted to maintain steady heart rate and blood pressure at the beginning of the study and then generally not altered thereafter. Changes in vapor concentrations, however, were made to ensure adequate depth of anesthesia according to clinical judgment. Intravenous crystalloid solutions (15 to 30 mL/kg) were infused during the study.
All interventions and MR scans were carried out under the same general anesthetic in an x-ray/MR hybrid laboratory (consisting of an x-ray Artis biplane system and a 1.5-T Avanto MR scanner, Siemens Medical Solutions, Erlangen, Germany). Patients were initially placed in the MR scanner, and biventricular volumes and great vessel blood flow were assessed. Patients were then transferred to the biplane catheter laboratory with the use of a mechanized sliding table that allows bidirectional transfer between the MR scanner and the catheterization laboratory (Miyabe, Siemens Medical Solutions). After hemodynamic assessment, BMS of the stenotic RVOT was performed. The hemodynamic assessment was repeated, and an MR-compatible balloon wedge pressure catheter (Arrow, Reading, Pa) was placed in the pulmonary artery to avoid renegotiation of the BMS during the subsequent PPVI. All wires were removed, and the patient was transferred back into the MR scanner for repeat assessment of biventricular volumes and great vessel blood flow. A third transfer back into the catheterization laboratory was carried out, and PPVI was performed within the previously placed stent. After a post-PPVI hemodynamic assessment was performed, the patient was transferred 1 last time into the MR scanner, where biventricular volumes and great vessel blood flow were assessed (Figure) .
Catheterization Protocol
Vascular access was achieved through the femoral vein and artery. Standard right heart catheterization, including pressure measurements and RVOT angiography, was undertaken. Invasive systemic pressures were monitored. Aortic root angiography was performed routinely to assess the proximity of the coronary arteries to the RVOT to avoid possible coronary compression caused by the BMS or PPVI. Simultaneous balloon inflation in the RVOT and coronary angiography were performed in patients at risk for coronary obstruction. 6, 11, 23, 24 Very stenotic, tortuous conduits were predilated with high-pressure Mullins balloons (NuMed, Hopkinton, NY). Balloonexpandable IntraStent Max LD stents (ev3 Intravascular, Plymouth, Minn) or covered CP stents (NuMed) were used for BMS of the RVOT. Stents were delivered and deployed with BIB catheters (NuMed). Hemodynamic measurements were repeated after BMS. PPVI was performed within the BMS. The device and technique used have been described elsewhere. 13, 25 After PPVI, pressure measurements and RVOT angiography were performed. Postdilatation with high-pressure Mullins balloons (NuMed) was performed after BMS or PPVI if appropriate.
MR Imaging Protocol
The same imaging protocol was used for MR scans before BMS, after BMS, and after PPVI. MR imaging was performed at 1.5 T (Avanto, Siemens). Retrospectively gated steady-state freeprecession cine images were acquired in the vertical long-axis and 4-chamber views. They were used to plan the short-axis stack, which included the extent of both ventricles (9 to 12 slices). The cine steady-state free-precession sequence parameters were as follows: repetition time, 2.4 ms; echo time, 1.1 ms; flip angle, 60°; slice thickness, 8 to 10 mm (no gap in short-axis stack); matrix, 192ϫ144; and field of view, 280 to 380 mm, with 25 phases per cardiac cycle.
Assessment of RV and left ventricular (LV) volumes was performed by manually defining the endocardial outline at end diastole and end systole in each of the short-axis cine images (Argus, Siemens Medical Systems). The end-diastolic volume (EDV) and end-systolic volume were calculated with Simpson's rule for each ventricle, and from these volumes, the stroke volume (SV) and ejection fraction (EF) were derived.
Flow data were acquired with a flow-sensitive gradient echo sequence (repetition time, 6.4 ms; echo time, 3.2 ms; flip angle, 30°; slice thickness, 3 mm; and matrix, 256ϫ192, with 40 phases per cardiac cycle) during free breathing. Pulmonary blood flow was calculated from flow measurements in both branch PAs to avoid possible artifact caused by the stents in the RVOT after BMS or PPVI. 26, 27 Flow was calculated from the phase-contrast images using a semiautomatic vessel edge-detection algorithm with operator correction. Regurgitant fraction was calculated as the percent of backward flow over forward flow. When pulmonary regurgitation was present, an effective RV SV was calculated to reflect the net forward blood flow into the PAs as follows: effective RV SVϭtotal PA forward flowϪPA backward flow. All volume and flow measurements were indexed for body surface area and expressed in milliliters per square meter.
A subset of patients (11 of 14) underwent cardiac MR imaging while awake before the interventions and within 1 week after interventions. The changes in cardiac output and heart rate after the interventions were assessed.
Cardiopulmonary exercise testing before the interventions and within 1 month after the interventions was performed in 12 of 14 patients, and peak oxygen uptake was determined. The protocol for cardiopulmonary exercise testing has been described previously. 12 
Statistical Analysis
Data are expressed as meanϮSD. MR and pressure data were compared by use of repeated-measures ANOVA and posthoc testing (Bonferroni) between the pre-BMS, post-BMS, and post-PPVI states. MR data acquired in awake patients and cardiopulmonary exercise data before and after the interventions were compared by use of the paired Student t test. A value of PϽ0.05 was considered statistically significant. Statistical testing and data analysis were performed with SPSS version 15.0 (SPSS Inc, Chicago, Ill).
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Patient Characteristics
The patient characteristics are shown in Table 1 . The median age of the patient population was 12.9 years (range, 9.9 to 17.8 years). The majority of children (9 of 14) had tetralogy of Fallot or a variant morphology. RV to PA conduits were present in all but 1 patient, who presented with a stenosed bioprosthesis in the pulmonary position. All patients except 1 were symptomatic (New York Heart Association functional class Ͼ1; see Table 1 for details). Before the procedure, a ratio of RV to systemic pressure Ͼ0.75 was present in 9 of 14.
Procedural Results
The total procedure, catheterization, and fluoroscopy times were 209Ϯ14, 92Ϯ14, and 21Ϯ12 minutes, respectively. The time frames for each of the individual steps included in the study protocol are summarized in the Figure. BMS and PPVI were successful in all patients. There were no major complications. In 1 patient, a guidewire injury caused minor lung bleeding, which was treated conservatively. In total, 16 IntraStent Max LD stents (ev3 Intravascular) were implanted into 13 patients. In 1 patient with a small conduit (16 mm), a covered CP stent (NuMed) was used. In 2 patients with tortuous and severely obstructed conduits, predilatation was performed. High-pressure balloon dilatation after BMS was performed in 4 patients and after PPVI in 6 patients.
Hemodynamic Outcome
Invasive pressure measurements before BMS, after BMS, and after PPVI are summarized in Table 2 . BMS resulted in a significant reduction in RV systolic pressure (63Ϯ14 versus 37Ϯ11 mm Hg; PϽ0.001, posthoc testing, before versus after BMS), PA to RV pullback gradient (43Ϯ11 versus 13Ϯ7 mm Hg; PϽ0.001), and ratio of RV to systemic pressure (0.75Ϯ0.17% versus 0.41Ϯ0.14%; PϽ0.001).
There was no significant further change in RV systolic pressure, PA to RV gradient, or ratio of RV to systemic pressure between after BMS and after PPVI (39Ϯ13 mm Hg, Pϭ0.76; 15Ϯ8 mm Hg, Pϭ1.0; 0.42Ϯ0.11, Pϭ1.0, respectively). The PA diastolic pressure increased after PPVI, reflecting the restoration of pulmonary valvular competence (9Ϯ4 mm Hg before BMS versus 11Ϯ6 mm Hg after PPVI; Pϭ0.048). Systemic pressures remained unchanged after BMS but increased slightly after PPVI (85Ϯ7 mm Hg before BMS versus 85Ϯ7 mm Hg after BMS versus 93Ϯ12 mm Hg after PPVI).
MR Volumes and Ventricular Function
MR parameters are summarized in Table 3 In the subset of patients, who underwent preintervention and postintervention cardiac MR scans while awake, there was a significant increase in cardiac output (3.2Ϯ0.4 mL · min Ϫ1 · m Ϫ2 before intervention versus 3.8Ϯ0.6 mL · min Ϫ1 · m Ϫ2 after intervention; Pϭ0.004), whereas heart rate did not change significantly (73.0Ϯ9.0 versus 75.5Ϯ9.3 bpm; Pϭ0.042).
On cardiopulmonary exercise testing, peak oxygen uptake (peak V O 2 ) expressed as percentage of predicted peak V O 2 increased significantly from 67.6Ϯ19.8% to 75.7Ϯ15.3% (Pϭ0.048) after intervention.
Discussion
Over the last decade, BMS has been the nonsurgical treatment of choice for stenotic RV to PA conduits. However, this intervention has a significant drawback in that relief of stenosis leads to the creation of free pulmonary regurgitation. Cardiac catheterization studies have shown a reduction in the RVOT gradient and RV systolic pressure, 5-10 which has been described as a positive procedural outcome. However, none of the previous studies have assessed the full hemodynamic consequences of BMS, particularly the impact of acute pulmonary regurgitation on RV and LV function. In this study, we show that a thorough assessment of cardiac pressures, biventricular function, and great vessel blood flow reveals the superior acute hemodynamic consequences of PPVI over BMS.
Physiological Comparison of BMS Versus PPVI
In our patients, BMS led to significant relief of the RVOT gradient and RV pressure. This reduction in RV afterload led to a lower RV end-systolic volume and therefore higher RV SV and EF. Nevertheless, as a result of the creation of free pulmonary regurgitation (pulmonary regurgitation fraction Ͼ40%), there was no improvement in effective RV SV, ie, the net pulmonary forward blood flow. Conversely, after PPVI, effective RV SV increased with no further changes in RVOT gradient or RV systolic pressure. PPVI also resulted in increases in LVEDV and effective LV SV that were not observed after BMS. If we consider only the catheter-measured hemodynamic changes in our study, we observe that BMS and PPVI have similar beneficial effects (reduced RVOT gradient, reduced RV pressures). However, when catheter and MR data are interpreted together, it can be seen that biventricular effective SVs and efficiency improve only after PPVI. Fundamentally, inducing free pulmonary regurgitation by BMS converts the RV from a ventricle with increased pressure work to a ventricle with increased volume work. In this situation, the ratio between effective RV SV and RV external work could be considered to remain at a similar level. On the other hand, revalvulation with PPVI results in a reduction in RV SV at maintained low RV pressures. Hence, this intervention reduces the external work of the RV with increased effective RV SV, leading to an improved RV efficiency, which in turn should reduce myocardial oxygen consumption.
The increase in effective RV and LV SV after PPVI was accompanied by a significant drop in heart rate. Consequently, cardiac output did not change after BMS or PPVI. We have previously described an increase in cardiac output after PPVI when patients are assessed with MR imaging while awake (ie, no general anesthetic). 12, 28 Similarly, in the subset of patients in this study who underwent MR scans while awake before and after the interventions, cardiac output increased significantly, whereas heart rate remained unchanged. Although cardiac output and heart rate might be more susceptible to alterations in sympathetic activation when assessed in patients who are awake, these findings could indicate that these patients were slightly decompensated before intervention and therefore show a postprocedure improvement in cardiac output.
In patients under general anesthesia, we would argue that because oxygen demand is likely to be low, there is little physiological drive to increase the cardiac output. Therefore, when effective RV and LV SVs increase after a reduction in both RV pressure and volume overload, the physiological feedback is to reduce heart rate. We therefore speculate that the drop in heart rate that we observed represents an adaptation to the increase in effective RV and LV SV after PPVI at unchanged oxygen demands. This again suggests an improvement in biventricular efficiency that occurs only after PPVI, not after BMS.
Use of an X-Ray/MR Hybrid Laboratory
In this study, we have used an x-ray/MR hybrid laboratory to compare the impact of BMS and PPVI on biventricular physiology in a 2-staged sequential procedure, with patients serving as their own controls. This not only enabled accurate quantification of physiology in terms of pressure measurements, ventricular function, and great vessel blood flow but offered the potential to compare the acute hemodynamic outcome of sequential interventions (BMS and PPVI). This represents a novel utility of such hybrid laboratories in humans to assess physiological changes after interventions in 
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a more comprehensive way and might have the potential to influence future patient management.
Study Limitations
Because this study assessed only the acute response to BMS and PPVI, our findings cannot speak to the relative clinical impact of BMS and PPVI in children with obstructed RVOT conduits. Pressure data and volume/flow data were not acquired simultaneously but sequentially, including several transfers between the catheterization laboratory and the MR scanner. Although probably minimized by general anesthesia, small variations in the physiological activation of the patients cannot be excluded. Similarly, because oxygen demand and consumption during the procedure were not assessed, small perturbations in the depth of the general anesthesia also cannot be excluded. Finally, when cardiac physiology is assessed under general anesthesia, it could potentially differ from assessment in awake patients.
Conclusions
The results of this study suggest the superiority of PPVI over BMS for improving biventricular efficiency in patients with RVOT obstruction in the acute setting. This was assessed by the use of an x-ray/MR hybrid laboratory, which allowed a detailed assessment of hemodynamics and, in particular, ventricular function and efficiency before and after interventions.
The results of this study should enhance our understanding of biventricular physiology after altering RV loading conditions. Future studies might include simultaneous acquisition of pressure and volume data to reconstruct pressure-volume loops of the RV and LV, which potentially could provide deeper insight into the systolic and diastolic ventricular interaction after correction of pathological RV loading conditions.
